BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12679656)

  • 1. Report of a child with vitiligo and Evans syndrome.
    Muwakkit S; Locatelli F; Abboud M; Razzouk B; Wilimas J
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):344-5. PubMed ID: 12679656
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of refractory Evans' syndrome with cyclosporine and prednisone.
    Uçar B; Akgün N; Aydoğdu SD; Kirel B; Idem S
    Pediatr Int; 1999 Feb; 41(1):104-7. PubMed ID: 10200147
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic stem cell transplantation for Evans syndrome.
    Oyama Y; Papadopoulos EB; Miranda M; Traynor AE; Burt RK
    Bone Marrow Transplant; 2001 Nov; 28(9):903-5. PubMed ID: 11781654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of Evans syndrome secondary to COVID-19.
    Demir NA; Basturk A; Ural O; Sumer S; Erdogdu B; Kiratli HE; Celik JB; Koplay M; Vatansev H
    Blood Transfus; 2021 Jan; 19(1):85-88. PubMed ID: 33263526
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment-resistant infantile Evans syndrome.
    Muwakkit S; Rachid R; Bazarbachi A; Araysi T; Dbaibo GS
    Pediatr Int; 2001 Oct; 43(5):502-4. PubMed ID: 11737713
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab in autoimmune cytopenias: for which patients?
    Finazzi G
    Haematologica; 2002 Feb; 87(2):113-4. PubMed ID: 11836158
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitiligo, chronic thrombocytopenia, and autoimmune hemolytic anemia.
    Walters TR; Lerner AB; Nordlund JJ
    Arch Dermatol; 1978 Sep; 114(9):1366-7. PubMed ID: 686752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Castleman's disease in association with Evan's syndrome and vitiligo.
    Marsh JH; Colbourn DS; Donovan V; Staszewski H
    Med Pediatr Oncol; 1990; 18(2):169-72. PubMed ID: 2304424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How I manage Evans Syndrome and AIHA cases in children.
    Miano M
    Br J Haematol; 2016 Feb; 172(4):524-34. PubMed ID: 26625877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating immunobullous diseases: an update.
    Reynaert S; Black MM
    Dermatol Nurs; 2004 Feb; 16(1):29-34, 70. PubMed ID: 15022502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained remission of CIDP associated with Evans syndrome.
    Knecht H; Baumberger M; Tobòn A; Steck A
    Neurology; 2004 Aug; 63(4):730-2. PubMed ID: 15326255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete remission of refractory anemia following a single high dose of cyclophosphamide.
    Ferrara F; Copia C; Annunziata M; di Noto R; Russo C; Palmieri S; Spasiano A; del Vecchio L
    Ann Hematol; 1999 Feb; 78(2):87-8. PubMed ID: 10089024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evans syndrome: successful management with multi-agent treatment including intermediate-dose intravenous cyclophosphamide.
    Gombakis N; Trahana M; Athanassiou M; Kanakoudi-Tsakalidou F
    J Pediatr Hematol Oncol; 1999; 21(3):248-9. PubMed ID: 10363861
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome.
    Carey EJ; Somaratne K; Rakela J
    Rev Med Chil; 2011 Nov; 139(11):1484-7. PubMed ID: 22446656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune hematologic complications in malignant lymphoproliferative disorders.
    Sacks PV
    Arch Intern Med; 1974 Oct; 134(4):781-3. PubMed ID: 4606256
    [No Abstract]   [Full Text] [Related]  

  • 17. Alemtuzumab for giant cell hepatitis with autoimmune hemolytic anemia.
    Rovelli A; Corti P; Beretta C; Bovo G; Conter V; Mieli-Vergani G
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):596-9. PubMed ID: 18030239
    [No Abstract]   [Full Text] [Related]  

  • 18. Complications of a severe autoimmune hemolytic anemia crisis: transfusional iron overload and gangrenous cholecystitis.
    Menchetti I; Lin Y; Cserti-Gazdewich C; Goldstein J; Law C; Lazarus A; Callum JL
    Transfusion; 2018 Dec; 58(12):2777-2781. PubMed ID: 30291762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of severe chronic autoimmune hemolytic anemia with low dose cyclosporine and prednisone in an infant.
    Yarali N; Fişgin T; Kara A; Duru F
    Turk J Pediatr; 2003; 45(4):335-7. PubMed ID: 14768800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evans' syndrome in paroxysmal nocturnal hemoglobinuria.
    Conti L; Iurlo A; Gandolfo GM; Girelli G
    Acta Haematol; 1985; 73(4):210-1. PubMed ID: 3933242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.